Literature DB >> 20127525

Phospholipase A2 and its molecular mechanism after spinal cord injury.

Nai-Kui Liu1, Xiao-Ming Xu.   

Abstract

Phospholipases A(2) (PLA(2)s) are a diverse family of lipolytic enzymes which hydrolyze the acyl bond at the sn-2 position of glycerophospholipids to produce free fatty acids and lysophospholipids. These products are precursors of bioactive eicosanoids and platelet-activating factor which have been implicated in pathological states of numerous acute and chronic neurological disorders. To date, more than 27 isoforms of PLA(2) have been found in the mammalian system which can be classified into four major categories: secretory PLA(2), cytosolic PLA(2), Ca(2+)-independent PLA(2), and platelet-activating factor acetylhydrolases. Multiple isoforms of PLA(2) are found in the mammalian spinal cord. Under physiological conditions, PLA(2)s are involved in diverse cellular responses, including phospholipid digestion and metabolism, host defense, and signal transduction. However, under pathological situations, increased PLA(2) activity, excessive production of free fatty acids and their metabolites may lead to the loss of membrane integrity, inflammation, oxidative stress, and subsequent neuronal injury. There is emerging evidence that PLA(2) plays a key role in the secondary injury process after traumatic spinal cord injury. This review outlines the current knowledge of the PLA(2) in the spinal cord with an emphasis being placed on the possible roles of PLA(2) in mediating the secondary SCI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127525      PMCID: PMC9169014          DOI: 10.1007/s12035-010-8101-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  37 in total

Review 1.  Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders.

Authors:  A A Farooqui; M L Litsky; T Farooqui; L A Horrocks
Journal:  Brain Res Bull       Date:  1999-06       Impact factor: 4.077

Review 2.  The phospholipase A2 superfamily and its group numbering system.

Authors:  Ralph H Schaloske; Edward A Dennis
Journal:  Biochim Biophys Acta       Date:  2006-08-03

Review 3.  Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders.

Authors:  Akhlaq A Farooqui; Wei-Yi Ong; Lloyd A Horrocks
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 4.  Secretory phospholipases A2.

Authors:  M Murakami; I Kudo; K Inoue
Journal:  J Lipid Mediat Cell Signal       Date:  1995-10

Review 5.  Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2.

Authors:  Kohji Hanasaki; Hitoshi Arita
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

Review 6.  Phospholipase A2 and its role in brain tissue.

Authors:  A A Farooqui; H C Yang; T A Rosenberger; L A Horrocks
Journal:  J Neurochem       Date:  1997-09       Impact factor: 5.372

Review 7.  Phospholipase A2.

Authors:  Makoto Murakami; Ichiro Kudo
Journal:  J Biochem       Date:  2002-03       Impact factor: 3.387

Review 8.  The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration.

Authors:  Eugene Park; Alexander A Velumian; Michael G Fehlings
Journal:  J Neurotrauma       Date:  2004-06       Impact factor: 5.269

Review 9.  A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders.

Authors:  John W Phillis; Michael H O'Regan
Journal:  Brain Res Brain Res Rev       Date:  2004-01

10.  PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron.

Authors:  Neil V Morgan; Shawn K Westaway; Jenny E V Morton; Allison Gregory; Paul Gissen; Scott Sonek; Hakan Cangul; Jason Coryell; Natalie Canham; Nardo Nardocci; Giovanna Zorzi; Shanaz Pasha; Diana Rodriguez; Isabelle Desguerre; Amar Mubaidin; Enrico Bertini; Richard C Trembath; Alessandro Simonati; Carolyn Schanen; Colin A Johnson; Barbara Levinson; C Geoffrey Woods; Beth Wilmot; Patricia Kramer; Jane Gitschier; Eamonn R Maher; Susan J Hayflick
Journal:  Nat Genet       Date:  2006-06-18       Impact factor: 38.330

View more
  25 in total

1.  Inhibition of cPLA2 activation by Ginkgo biloba extract protects spinal cord neurons from glutamate excitotoxicity and oxidative stress-induced cell death.

Authors:  Zhen Zhao; Naikui Liu; Jingya Huang; Pei-Hua Lu; Xiao-Ming Xu
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

2.  Neuroprotective effects of testosterone on motoneuron and muscle morphology following spinal cord injury.

Authors:  James S Byers; Anna L Huguenard; Dulanji Kuruppu; Nai-Kui Liu; Xiao-Ming Xu; Dale R Sengelaub
Journal:  J Comp Neurol       Date:  2012-08-15       Impact factor: 3.215

3.  Protective Effects of Estradiol and Dihydrotestosterone following Spinal Cord Injury.

Authors:  Dale R Sengelaub; Qi Han; Nai-Kui Liu; Melissa A Maczuga; Violetta Szalavari; Stephanie A Valencia; Xiao-Ming Xu
Journal:  J Neurotrauma       Date:  2018-01-11       Impact factor: 5.269

Review 4.  Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.

Authors:  Yulong Liu; Lisa B E Shields; Zhongwen Gao; Yuanyi Wang; Yi Ping Zhang; Tianci Chu; Qingsan Zhu; Christopher B Shields; Jun Cai
Journal:  Mol Neurobiol       Date:  2016-09-09       Impact factor: 5.590

5.  Neuroprotective ferulic acid (FA)-glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord.

Authors:  Wei Wu; Seung-Young Lee; Xiangbing Wu; Jacqueline Y Tyler; He Wang; Zheng Ouyang; Kinam Park; Xiao-Ming Xu; Ji-Xin Cheng
Journal:  Biomaterials       Date:  2013-12-12       Impact factor: 12.479

6.  Dietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injury.

Authors:  Johnny D Figueroa; Kathia Cordero; Miguel S Llán; Marino De Leon
Journal:  J Neurotrauma       Date:  2013-02-06       Impact factor: 5.269

Review 7.  Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.

Authors:  James C-M Lee; Agnes Simonyi; Albert Y Sun; Grace Y Sun
Journal:  J Neurochem       Date:  2011-01-07       Impact factor: 5.372

8.  Attenuated Reactive Gliosis and Enhanced Functional Recovery Following Spinal Cord Injury in Null Mutant Mice of Platelet-Activating Factor Receptor.

Authors:  Yuanyi Wang; Zhongwen Gao; Yiping Zhang; Shi-Qing Feng; Yulong Liu; Lisa B E Shields; Ying-Zheng Zhao; Qingsan Zhu; David Gozal; Christopher B Shields; Jun Cai
Journal:  Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.590

9.  Comparative analysis of molecular mechanism of spinal cord injury with time based on bioinformatics data.

Authors:  T Wen; J Hou; F Wang; Y Zhang; T Zhang; T Sun
Journal:  Spinal Cord       Date:  2015-10-27       Impact factor: 2.772

10.  Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury.

Authors:  Jennifer N Dulin; Edward D Karoly; Ying Wang; Henry W Strobel; Raymond J Grill
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.